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Abstract 
Background: To compare outcome of Tricuspid 
Regurgitation (TR)  between De Vaga technique and 
ring annuplasty in term of achieving adequate 
pulmonary artery pressure (PAP) and functional  
outcome.  
Methods:  In this comparative study adult 
patients(n=100) who underwent Mitral valve surgery 
with Tricuspid repair were enrolled and divided into 
two groups .Group A underwent MVR and TR repair 
using DEVAGA Technique (n=50) and group B had 
MVR  with Tricuspid Repair Ring Annuloplasty 
(n=50). In the De Vega annuloplasty technique, 2 
pledgeted parallel running 4-0 polypropylene 
stitches are placed at 3-4-mm intervals in a 
semicircular manner from the postero-septal to the 
antero-lateral commissure and tied. A valve gauge 
appropriate to the body surface area was used to 
determine the amount of anterior and posterior 
annular constriction.    
Results: Females were predominant in this study. 
The duration of surgery was found out to be 66.4 
minutes in group A compared to 71.0 minutes in 
group B(statistically not significant). Stay in the ICU 
and overall hospital stay was also found similar in 
both groups (p-value, 0.68). There was no statistically 
significant difference in postoperative functional 
capacity distribution (PAP) according to the surgical 
technique (p-value, 0.19).  
Conclusion: Devaga repair is as durable as 
prosthetic ring annuloplasty with added benefits of 
simple, cost effective and time saving technique. 
Key Words; Tricuspid regurgitation, Devaga, Ring 
annuplasty,  
 
Introduction: 
Secondary tricuspid regurgitation (TR), is repaired 
through adequate treatment of mitral valve disease by 
performing surgical treatment. It has been reported 
that even after appropriate correction of the left-sided 
pathology the secondary TR does not regress in a 
number of cases. Thus, it indicates moving towards a 
more definite intervention for repair of TR.Initially it 
was considered that in most patients with secondary 
tricuspid regurgitation (TR), the problems of right side 
would be corrected after appropriate surgical 
treatment of mitral valve disease with no touch 
technique i.e. conservative treatment of tricuspid valve 
regurgitation was recommended.1,2    
In the present circumstances It has been reported that 
even after appropriate correction of the left-sided 
pathology the secondary TR does not regress in a 
number of cases. Thus, the indications for surgery of 
the TR have progressively moved towards a more 
definite  intervention.3     
Isolated Tricuspid valve lesion is very rare, most 
commonly associated with left heart pathology.   
Patients most commonly present with dyspnea and 
lethargy. Systemic venous hypertension, pulsatile 
hepatomegaly, ascites and peripheral edema may 
accompany any valve lesion, but are most commonly 
associated with severe tricuspid valve disease either 
regurgitation or stenosis. Functional TR invariably 
reflects right heart failure/ volume overload. As the 
septal leaflet is part of the central fibrous skeleton, 
annular dilatation naturally involves the anterior and 
posteroinferior portion.4  
The characteristic history of extreme TR incorporates a 
delayed asymptomatic period with advance 
development of right atrium and RV because of 
volume over-burden. Recently, Shiran et al described 
that expanded pulmonary artery pressure and 
permanent atrial fibrillation were the most dominant 
hazard factors for TR progression.5 
The reconstructive valve surgery is targeted to prevent 
annular dilatation by preserving leaflet mobility and 
hence creating a larger surface of coaptation.6,7 
Tricuspid Valve annuloplasty is the basis of current 
surgical therapy for severe TR and aims to correct 
annular dilation and restore annular geometry, 
resulting in improved leaflet coaptation. In this study 
two annuplasty techniques i.e. De Vaga technique and 
ring annuplasty were compared in terms of TR 
outcome.  
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Patients and Methods 
In this  comparative study adult patients, who 
underwent MVR Plus Tricuspid valve repair at 
Pakistan Institute of Medical Sciences, Islamabad, Bilal 
Hospital and Quaid-e-Azam International Hospital 
were included.All patients underwent similar 
preoperative preparations for different cardiac 
procedures using standard median sternotomy. Both 
groups comprised of similar sample of cases (n=50 
each). Between September 2010 and September 2016, a 
total of 100 patients who underwent mitral valve 
surgery with tricuspid repair were enrolled in this 
study and divided into two groups: Group A 
underwent MVR and TR repair using DEVAGA 
Technique (n=50) and Group B had MVR  with 
Tricuspid Repair Ring Annuloplasty (n=50). In the De 
Vega annuloplasty technique, 2 pledgeted parallel 
running 4-0 polypropylene stitches are placed at 3-4-
mm intervals in a semicircular manner from the 
posteroseptal to the anterolateral commissure and tied. 
A valve gauge appropriate to the body surface area 
was used to determine the amount of anterior and 
posterior annular constriction. The suture was 
fastened in the anterolateral commissure, passing 
through pledgets at each of the 2 ends. For the suture 
methods (De Vega and modified De Vega), Hegar 
dilators were used as valve gauges to estimate the 
valve size during the tying of the sutures. In ring 
tricuspid annuloplasty, we used a ring of appropriate 
size (determined by the length of the base of the 
tricuspid septal leaflet). To avoid rhythm 
complications, no sutures were used in the septal 
leaflet.  
Euro score was used in preoperative assessment of all 
patients for standardizing the risk and expected 
outcome.  Elective valvular heart surgery patients and 
age over 18 years were kept as inclusion criteria. 
Exclusion criteria for the patients were, patient with 
MVR OR DVR without tricuspid  involvement Redo 
valvular surgery and endocarditis  vegetation  MVR  
with CABG. Patients were evaluated with the help of 
daily progress parameters. Later on selected patients 
were followed up in outdoor clinic first weekly then 
following two weeks and monthly basis follow up for 
initial half year post operation for PT/INR and overall 
check up. Chi square test was applied to compare 
categorical variables whereas student’s t-test was 
applied to compare continuous numerical variables.  
 
Results 
Female gender was predominant in this study. Out of 
the total 50 cases in group A, 15 (30.0%) were male and 
35 (70.0%) were female whereas in group B, there were 
18 (36.0%) males and 32 (64.0%) female patients. The 
mean age of patients was 32.5 ± 11.2 years in group A 
compared to 29.4 ± 10.3 years in group B. The clinical 
parameters like hypertension, diabetes mellitus, COPD 
were found equal between the two study groups 
(Table 1).  
 
Table 1: Demographic and Clinical Characteristics of 
Patients in the Two Groups 
 De Vaga 
group  
(n=50) 
Ring 
Annuplasty 
group (n=50) 
p-value 
Age (years) 
  <40 22 (44.0%) 23 (46.0%) 0.84 
  >40 28 (56.0%) 27 (54.0%) 
Sex 
  Male 15 (30.0%) 18 (36.0%) 0.63 
  Female 35 (70.0%) 32 (64.0%) 
Hypertension 3 (6.0%) 2 (4.0%) 1.0 
DM 0 (0.0%) 2 (4.0%) 0.49 
Tricuspid annulus 
diameter (mm) 
47.5±3.2 43.4±3.6 0.27 
NYHA class 
  III 38 (76.0%) 32 (64.0%) 0.27 
  IV 12 (24.0%) 18 (36.0%) 
COPD 6 (12.0%) 8 (16.0%) 0.77 
PAP mmHg 45.6±11.2 43.8±10.0 0.76 
Creatinine 
  <1.7 42 (84.0%) 39 (78.0%) 0.19 
  >1.7 8 (16.0%) 11 (22.0%) 
AFR 
  AFR 35 (70.0%) 33 (66.0%) 0.83 
  SR 5 (10.0%) 6 (12.0%) 
LVEF 
  <40 9 (18.0%) 13 (26.0%) 0.46 
  >40 41 (82.0%) 37 (74.0%) 
 
The duration of surgery was found out to be 66.4 
minutes in group A compared to 71.0 minutes in 
group B. Though De Vaga group had slightly shorter 
operative time, this difference was not statistically 
significant (p-value, 0.27). Similarly, the stay in the 
ICU and overall hospital stay was also found similar in 
both groups (p-value, 0.68) (Table 2). Medium-term 
(25.4 ± 10.3 mo) freedom from the development of 
recurrent grades 3 and 4 Tricuspid Insufficiency in the 
De Vega, annuloplasty groups and Ring annuloplasty 
group was  76.9%, and 83.9% respectively (p-value, 
0.30). 
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Table 2: Comparison of operative and perioperative 
findings between the two groups 
 De Vaga 
group 
(n=50) 
Ring 
Annuplasty 
group  
(n=50) 
p-value 
Operative time 
   Cross X 
clamp time 
(min) 
66.4 ± 23.4 71.0 ± 18.3 0.27 
TPT 
time(min)  
91.2 ± 26.3 98.3 ± 29.4 0.18 
ICU 
stay(days)  
2.4 ± 1.2 2.6 ± 1.2 0.39 
Hospital stay 
(days) 
7.2 ± 1.2 7.4 ± 1.4 0.68 
Concomitant procedure 
   MVR 32 (64.0%) 34 (68.0%) 0.83 
   DVR 18 (36.0%) 16 (32.0%) 
Hemorrhage 3 (6.0%) 2 (4.0%) 1.0 
Renal failure 2 (4.0%) 3 (6.0%) 1.0 
Infection 1 (2.0%) 2 (4.0%) 1.0 
In hospital 
mortality 
2 (4.0%) 1 (2.0%) 1.0 
Heart block 4 (8.0%) 6 (12.0%) 0.74 
Reverted 3 (6.0%) 4 (8.0%) 1.0 
PPM 1 (2.0%) 2 (4.0%) 1.0 
Persistent AF 2 (4.0%) 3 (6.0%) 1.0 
Recurrent AF 5 (10.0%) 6 (12.0%) 1.0 
 
Table 3: Comparison of Pulmonary Artery Pressure 
Between the Two Study Groups 
 Preoperativ
e 
Immediate 
postoperative 
DEVAGA 50.9 ± 12.4 44.0 ± 13.6 
Ring Annuplasty 45.6 ± 14.5 40.6 ± 12.6 
P-value 0.06 0.19 
 
In echocardiographic results at the medium-term 
follow-up, it was revealed that the ratio of freedom 
from recurrent TI grades 3 and 4 was similar with both 
the De Vega group and the ring annuplasty group (p-
value, Symptom-free survival was 79.3% in the De 
Vega group, 88.4% in the ring group (P-value, 0.28). 
There was no statistically significant difference in 
postoperative functional capacity distribution (PAP) 
according to the surgical technique (P-value, 0.19), 
however, in both groups, immediate postoperative 
improvement was highly significant when compared 
with preoperative New York Heart Association 
(NYHA) classifications (p-value, 0.02) (Table 3). 
Discussion 
Tricuspid repair can be challenging for cardiac 
surgeons due to its indications and opting ideal 
surgical technique. Various surgical options are in use 
with varying outcomes. The aim of TR is to remodel 
annular structures by maintaining a trileaflet valve 
that is more physiologic, to maintain flexibility of right 
ventricular (RV) pumping action, and which can 
prevent redilation.7  
In the present study outcome of TR repair was 
compared among De Vaga technique and Ring 
annuplasty techniques and it was found out that both 
are similarly effective. The operative time, hospital 
stay were also found similar, moreover, fewer side 
effects were monitored and the rate of recurrence was 
also found equally distributed among the two study 
groups. Previous evidence supports the findings of 
current study. Huang X et al found that modified De 
Vega tricuspid annuloplasty is acceptable for TR and 
improvements in terms of echocardiographic status on 
long-term basis.8 Khallaf AN et al witnessed that 
Tricuspid repair with ring annuloplasty has excellent 
outcome, however, with no significant benefits over 
DeVega annuloplasty as observed at one year.9 
Bhagwan et al reported no significant difference 
between ring and De vaga annuplasty, they found 
similar results with both the techniques of TV repair 
when applied to functionally significant TR in a pre-
dominantly rheumatic population.10 Jung W et al 
witnessed that TR with the Tri-Ad ring corrected 
functional outcome effectively and provided good 
early clinical and echocardiographic results without 
ring-related complications.11 Guenther T and 
colleagues witnessed that Tricuspid valve repair with 
a ring annuloplasty is associated with improved 
survival and a lower reoperation rate than that with a 
suture annuloplasty.12 Bernal et al showed lesser re-
operation rate after ring annuloplasty compared to De 
Vega repair.13 Carrier et al showed similar outcome 
with both ring annuloplasty and De Vega techniques.14 
The above scientific evidence is comparable to the 
current study findings, however, there is slight 
variation also witnessed by many previous 
investigators.  
The current study describes both techniques equally 
successful in the recovery of TR. However, keeping the 
fact that Pakistan is a lower middle income country 
with limited healthcare facilities and low spending 
status of communities, De Vaga technique is more 
suitable for our local settings. De Vaga technique is 
effective, simple, easy and cost effective when 
compared with ring annuplasty.15,16 There is concern 
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regarding the recurrence rates associated with De 
Vaga annuplasty, however, modified options of this 
procedure can be used to overcome this limitation.17  
This study revealed no significant difference with 
respect to residual significant TR, neither in immediate 
follow-up nor at 6-month follow-up or later follow-
ups. These results could be attributed to single 
surgeon surgical technique and standardized post-
operative management and close follow-ups. In 
present study an adequate sample of patients was 
selected and followed up for a long period of 5 years 
which gave an in-depth view of the effect of the two 
study interventions.  
Conclusion 
1.Devaga repair is as durable as prosthetic ring 
annuloplasty with added benefits of simple, cost 
effective and time saving technique. 
2. Significant improvements both in overall and event-
free survival are  conferred by Devaga technique.  
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